Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03623945 · ClinicalTrials.gov registry record
Autoantibodies in Breast Cancer Detection
A clinical trial, sponsored by Sanford Health.
- Terminated
- Registry status
- 1,279
- Enrollment target
NCT03623945 is a clinical trial that was terminated before completion, run by Sanford Health. The registered enrollment target is 1,279 participants.
The verdict
NCT03623945 was terminated before completion, sponsored by Sanford Health.
- TERMINATED
- Registry status
- 1,279 participants
- Enrollment target
Study Summary
Prospective, single-center study in women who have recently had an abnormal mammogram followed by a breast biopsy or women who have recently had a normal screening mammogram. We are no longer enrolling women who had normal Screening mammograms.
Interventions
- OTHER Collection of blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,279 participants |
| Start Date | 2018-07-24 |
| Est. Completion | 2024-03-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03623945
The ClinicalTrials.gov registry entry for NCT03623945 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,279 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collection of blood is the first listed.
NCT03623945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03623945 about?
NCT03623945 is a clinical study titled "Autoantibodies in Breast Cancer Detection". Prospective, single-center study in women who have recently had an abnormal mammogram followed by a breast biopsy or women who have recently had a normal screening mammogram. We are no longer enrolling women who had normal Screening mammograms.
What is the current status of trial NCT03623945?
This trial is currently terminated. The enrollment target is 1,279 participants. The study started on 2018-07-24. Estimated completion is 2024-03-11.
What interventions are being tested in trial NCT03623945?
The interventions under investigation include: Collection of blood (OTHER).
Who is sponsoring clinical trial NCT03623945?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.